Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines

dc.contributor.authorArayssi, Thurayya K.
dc.contributor.authorHarfouche, Manale
dc.contributor.authorDarzi, Andrea J.
dc.contributor.authorAl-Emadi, Samar Ai
dc.contributor.authorAlnaqbi, Khalid A.
dc.contributor.authorBadsha, Humeira M.
dc.contributor.authoral-Balushi, Farida
dc.contributor.authorDib, Carole
dc.contributor.authorElzorkany, Bassel
dc.contributor.authorHalabi, Hussein Mohammed
dc.contributor.authorHammoudeh, Mohammed M.
dc.contributor.authorHazer, Wissam
dc.contributor.authorMasri, Basel K.
dc.contributor.authorMerashli, Mira
dc.contributor.authorOmair, Mohammed Ahmed
dc.contributor.authorSalloum, Nelly
dc.contributor.authorUthman, Imad W.
dc.contributor.authorZahirovic, Sumeja
dc.contributor.authorZiade Zoghbi, Nelly Raymond
dc.contributor.authorBannuru, Raveendhara R.
dc.contributor.authorMcAlindon, Timothy E.
dc.contributor.authorNomier, Mohamed A.
dc.contributor.authorSingh, Jasvinder A.
dc.contributor.authorChristensen, Robin D.K.
dc.contributor.authorTugwell, Peter S.L.
dc.contributor.authorSchunëmann, Holger J.
dc.contributor.authorAkl, Elie A.
dc.contributor.departmentInternal Medicine
dc.contributor.departmentEpidemiology and Population Health (EPHD)
dc.contributor.departmentClinical Research Institute
dc.contributor.departmentRheumatology
dc.contributor.departmentGRADE Center
dc.contributor.facultyFaculty of Health Sciences (FHS)
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:51:47Z
dc.date.available2025-01-24T11:51:47Z
dc.date.issued2018
dc.description.abstractClinical practice guidelines can assist rheumatologists in the proper prescription of newer treatment for rheumatoid arthritis (RA). The objective of this paper is to report on the recommendations for the management of patients with RA in the Eastern Mediterranean region. We adapted the 2015 American College of Rheumatology guidelines in two separate waves. We used the adolopment methodology, and followed the 18 steps of the “Guidelines 2.0” comprehensive checklist for guideline development. For each question, we updated the original guidelines’ evidence synthesis, and we developed an Evidence Profile (EP) and an Evidence to Decision (EtD) table. In the first wave, we adoloped eight out of the 15 original questions on early RA. The strength changed for five of these recommendations from strong to conditional, due to one or more of the following factors: cost, impact on health equities, the balance of benefits, and harms and acceptability. In the second wave, we adoloped eight out of the original 44 questions on established RA. The strength changed for two of these recommendations from strong to conditional, in both cases due to cost, impact on health equities, balance of benefits and harms, and acceptability. The panel also developed a good practice recommendation. We successfully adoloped 16 recommendations for the management of early and established RA in the Eastern Mediterranean region. The process proved feasible and sensitive to contextual factors. © 2018, The Author(s).
dc.identifier.doihttps://doi.org/10.1007/s10067-018-4245-5
dc.identifier.eid2-s2.0-85051693126
dc.identifier.pmid30097896
dc.identifier.urihttp://hdl.handle.net/10938/31023
dc.language.isoen
dc.publisherSpringer London
dc.relation.ispartofClinical Rheumatology
dc.sourceScopus
dc.subjectAdoloped
dc.subjectGuidelines
dc.subjectManagement
dc.subjectRecommendations
dc.subjectRheumatoid arthritis
dc.subjectAntirheumatic agents
dc.subjectArthritis, rheumatoid
dc.subjectEvidence-based medicine
dc.subjectHumans
dc.subjectMediterranean region
dc.subjectPractice guidelines as topic
dc.subjectRheumatology
dc.subjectSocieties, medical
dc.subjectUnited states
dc.subjectAbatacept
dc.subjectDisease modifying antirheumatic drug
dc.subjectGlucocorticoid
dc.subjectMethotrexate
dc.subjectTofacitinib
dc.subjectTumor necrosis factor inhibitor
dc.subjectAntirheumatic agent
dc.subjectArticle
dc.subjectBiological therapy
dc.subjectChecklist
dc.subjectCombination drug therapy
dc.subjectCost effectiveness analysis
dc.subjectDisease activity
dc.subjectDrug efficacy
dc.subjectGood clinical practice
dc.subjectHealth care cost
dc.subjectHealth equity
dc.subjectHuman
dc.subjectMonotherapy
dc.subjectPatient care
dc.subjectPhysician
dc.subjectPractice guideline
dc.subjectPriority journal
dc.subjectSouthern europe
dc.subjectTreatment outcome
dc.subjectEvidence based medicine
dc.subjectMedical society
dc.subjectStandards
dc.titleRecommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-7980.pdf
Size:
485.11 KB
Format:
Adobe Portable Document Format